Open in app
Sign inGet started
Go to opentargets
About
opentargets
A partnership to transform drug discovery through the systematic identification and prioritisation of targets
Note from the editor

Open Targets is an innovative, large-scale, multi-year, public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation. Visit the Open Targets Platform (https://www.targetvalidation.org) which provides an integration of public domain data to enable target identification and prioritisation.

Editors
Go to the profile of eliseo papa
eliseo papa
data scientist, engineer, doctor, geek, dad
Go to the profile of Luca Fumis
Luca Fumis
Go to the profile of Dr Denise Carvalho-Silva
Dr Denise Carvalho-Silva
Molecular biologist turned scientific outreach lead: training, writing, social media strategy, solutions. Formerly Ensembl, Wellcome Sanger Institute.
Go to the profile of Michaela Spitzer
Michaela Spitzer
Bioinformatician at Open Targets
Go to the profile of Andrew Hercules
Andrew Hercules
User research. Service design. Digital strategy. http://andrewhercules.com
Writers
Go to the profile of Andrea Pierleoni
Andrea Pierleoni
Go to the profile of Luca Fumis
Luca Fumis
Go to the profile of eliseo papa
eliseo papa
data scientist, engineer, doctor, geek, dad
Go to the profile of Aidan MacNamara
Aidan MacNamara
Go to the profile of Holly Foster
Holly Foster
Go to the profile of David Hulcoop
David Hulcoop
Go to the profile of Annalisa B
Annalisa B
Go to the profile of Maria Levchenko
Maria Levchenko
Scholarly comms expert and community manager at Europe PMC. My attempts to save the world are powered by mitochondria
Go to the profile of Helen Speedy
Helen Speedy
Go to the profile of Glenn Proctor
Glenn Proctor
Go to the profile of Zoë May Pendlington
Zoë May Pendlington